Avanos Medical Inc (NYSE:AVNS) Shares Sold by Commonwealth Equity Services LLC

Share on StockTwits

Commonwealth Equity Services LLC cut its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 6.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,766 shares of the company’s stock after selling 648 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Avanos Medical were worth $365,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in AVNS. RGM Capital LLC lifted its holdings in Avanos Medical by 1,659.3% during the 2nd quarter. RGM Capital LLC now owns 751,523 shares of the company’s stock worth $32,774,000 after buying an additional 708,806 shares in the last quarter. Paradice Investment Management LLC lifted its holdings in Avanos Medical by 17.8% during the 2nd quarter. Paradice Investment Management LLC now owns 1,991,583 shares of the company’s stock worth $86,853,000 after buying an additional 301,082 shares in the last quarter. Invesco Ltd. lifted its holdings in Avanos Medical by 21.0% during the 2nd quarter. Invesco Ltd. now owns 1,637,165 shares of the company’s stock worth $71,396,000 after buying an additional 284,234 shares in the last quarter. Nuveen Asset Management LLC acquired a new stake in Avanos Medical during the 2nd quarter worth approximately $8,718,000. Finally, Macquarie Group Ltd. lifted its holdings in Avanos Medical by 13.0% during the 2nd quarter. Macquarie Group Ltd. now owns 1,234,569 shares of the company’s stock worth $53,840,000 after buying an additional 142,386 shares in the last quarter. Institutional investors own 93.77% of the company’s stock.

A number of equities research analysts have issued reports on the stock. Raymond James lowered shares of Avanos Medical from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 6th. KeyCorp reduced their target price on shares of Avanos Medical from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Wednesday, November 6th. JMP Securities reiterated a “hold” rating on shares of Avanos Medical in a report on Wednesday, August 21st. Stifel Nicolaus lowered shares of Avanos Medical from a “buy” rating to a “hold” rating and reduced their price objective for the company from $45.00 to $35.00 in a report on Wednesday, November 6th. Finally, ValuEngine lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $44.80.

Shares of AVNS opened at $33.99 on Friday. Avanos Medical Inc has a twelve month low of $31.29 and a twelve month high of $53.45. The firm’s fifty day simple moving average is $38.45 and its 200-day simple moving average is $39.42. The firm has a market capitalization of $1.55 billion, a price-to-earnings ratio of 41.45 and a beta of 1.56. The company has a current ratio of 2.51, a quick ratio of 1.84 and a debt-to-equity ratio of 0.25.

Avanos Medical (NYSE:AVNS) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.30 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.32 by ($0.02). Avanos Medical had a negative net margin of 6.20% and a positive return on equity of 3.92%. The firm had revenue of $171.40 million during the quarter, compared to analyst estimates of $179.98 million. During the same quarter in the previous year, the business posted $0.37 earnings per share. Avanos Medical’s revenue for the quarter was up 3.8% compared to the same quarter last year. On average, analysts predict that Avanos Medical Inc will post 1.05 earnings per share for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.

Featured Story: What is the Bid-Ask Spread?

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical Inc (NYSE:AVNS).

Institutional Ownership by Quarter for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

$0.33 EPS Expected for Enphase Energy Inc  This Quarter
$0.33 EPS Expected for Enphase Energy Inc This Quarter
Zacks: Brokerages Anticipate Parsley Energy Inc  to Post $0.35 Earnings Per Share
Zacks: Brokerages Anticipate Parsley Energy Inc to Post $0.35 Earnings Per Share
-$0.62 Earnings Per Share Expected for Heron Therapeutics Inc  This Quarter
-$0.62 Earnings Per Share Expected for Heron Therapeutics Inc This Quarter
Blueprint Medicines  Given New $70.00 Price Target at Deutsche Bank
Blueprint Medicines Given New $70.00 Price Target at Deutsche Bank
FireEye  Given Neutral Rating at Piper Jaffray Companies
FireEye Given Neutral Rating at Piper Jaffray Companies
Penn National Gaming  Price Target Raised to $29.00 at JPMorgan Chase & Co.
Penn National Gaming Price Target Raised to $29.00 at JPMorgan Chase & Co.


© 2006-2019 Ticker Report